Chinese Journal of Pharmacovigilance ›› 2017, Vol. 14 ›› Issue (1): 4-6.
• Orignal Article • Previous Articles Next Articles
LIU Zhao-hua1, YAO Jing-chun2, SUN Rong3, GUO Yan-ru1, ZENG Fan-guang1
Received:
2017-02-16
Revised:
2017-02-16
Online:
2017-01-20
Published:
2017-02-16
CLC Number:
LIU Zhao-hua, YAO Jing-chun, SUN Rong, GUO Yan-ru, ZENG Fan-guang. Assessment of Immunosensitizing Potential of Shuanghuanglian for Injection Using Reporter Antigen Popliteal Lymph Node Assay[J]. Chinese Journal of Pharmacovigilance, 2017, 14(1): 4-6.
[1] 张玉生. 双黄连注射剂药物不良反应的探讨和研究[D], 济南:山东大学,2009. [2] 顾媛媛, 李殿明, 石朗,等. 注射用双黄连安全性问题研究近况[J]. 中国药房, 2015, (15):2156-2157. [3] Simons F E R, Frew A J, Ansotegui I J, et al. Risk assessment in anaphylaxis: current and future approaches[J]. J Allergy Clin Immunol,2007, 120(1): S2-24. [4] FDA. Guidance for Industry Immunotoxicology Evaluation of Investigational New Drugs[EB/OL].(2002-10-01)[2016-11-17].http://www.fda.gov/RegulatoryInformation/Guidances/default.htm. [5] CFDA.中药、天然药物免疫毒性(过敏性、光变态反应)研究技术指导原则[EB/OL].( 2007-08-23) [2016-11-17]. http://www.cde.org.cn/zdyz.do?method=initValue&frameStr=0. [6] CFDA.化学药物刺激性、过敏性和溶血性研究技术指导原则[EB/OL]. ( 2007-08-23) [2016-11-17]. http://www.cde.org.cn/zdyz.do?method=initValue&frameStr=0. [7] Tuschl H, Landsteiner H T, Kovac R. Application of the popliteal lymph node assay in immunotoxicity testing: complementation of the direct popliteal lymph node assay with flow cytometric analyses[J]. Toxicology, 2002, 172(1):35-48. [8] 刘兆华, 程芳, 周庚寅,等. C57BL/6J小鼠腘窝淋巴结试验评价注射用双黄连的致敏性研究[J]. 中国中西医结合杂志,2010, 30(1):64-67. [9] Aida T, Kimura T, Ishikawa N, et al. Evaluation of allergenic potential of low-molecular compounds by mouse popliteal lymph node assay[J].J Toxicol Sci, 1998, 23(5):425-432. [10] Løvik M, Alberg T, Nygaard U C, et al. Popliteal lymph node (PLN) assay to study adjuvant effects on respiratory allergy[J]. Methods,2007, 41(1):72-79. [11] Ravel G, Descotes J. Popliteal lymph node assay: facts and perspectives[J]. J Appl Toxicol, 2005, 25(6):451-458. [12] Gutting B W, Schomaker S J, Kaplan A H, et al. A comparison of the direct and reporter antigen popliteal lymph node assay for the detection of immunomodulation by low molecular weight compounds[J].Toxicol Sci, 1999, 51(1): 71-79. [13] Shinkai K, Nakamura K, Tsutsui N, et al. Mouse popliteal lymph node assay for assessment of allergic and autoimmunity-inducing potentials of low-molecular-weight drugs[J]. J Toxicol Sci, 1999, 24(2):95-102. [14] Carey J B, Allshire A, van Pelt F N. Immune modulation by cadmium and lead in the acute reporter antigen-popliteal lymph node assay[J]. Toxicol Sci, 2006, 91(1): 113-122. [15] Nierkens S, Pieters R. The Reporter Antigen Popliteal Lymph Node Assay[S/OL]. (2006-09-01)[2016-11-17]. http://www.currentprotocols.com/WileyCDA/CPUnit/refId-tx1812.html [16] 郝园, 孔翔瑜, 吴泰相. 277 篇 1486 例清开灵注射液不良反应/不良事件系统评价[J]. 中国循证医学杂志, 2010, 10(2): 162-175. [17] 程芳. 注射用双黄连类过敏反应及其机制研究[D]. 济南:山东大学,2009. [18] Uetrecht J. Idiosyncratic drug reactions: past, present, and future[J].Chem Res Toxicol, 2008, 21(1): 84-92. [19] Pieters R, Albers R. Screening tests for autoimmune-related immunotoxicity[J]. Environ Health Perspect, 1999, 107( Suppl 5): 673-677. [20] Pieters R. Detection of autoimmunity by pharmaceuticals[J]. Methods,2007, 41(1): 112-117. [21] Gutting B W, Updyke L W, Amacher D E. Amacher, Investigating the TNP-OVA and direct popliteal lymph node assays for the detection of immunostimulation by drugs associated with anaphylaxis in humans[J]. J Appl Toxicol, 2002, 22(3): 177-183. [22] Gutting B W, Updyke L W, Amacher D E. Diclofenac activates T cells in the direct popliteal lymph node assay and selectively induces IgG(1) and IgE against co-injected TNP-OVA[J]. Toxicol Lett, 2002, 131(3): 167-180. [23] Albers R, Broeders A, Van d P A, et al. The use of reporter antigens in the popliteal lymph node assay to assess immunomodulation by chemicals[J]. Toxicol Appl Pharmacol, 1997, 143(1): 102-109. [24] 张晶, 周富荣. 中药注射剂质量标准及有关问题评述[J]. 中药新药与临床药理, 2001, 12(002): 67-73. [25] Han J, Yan Y, Li C, et al. Involvement of Histamine and RhoA/ROCK in Penicillin Immediate Hypersensitivity Reactions[J].Scientific Reports, 2016, 6:33192. [26] 仇士东, 刘兆华,刘兆平. 双黄连注射剂导致类过敏反应的特点[J]. 中国药理学与毒理学杂志, 2013, 27(5): 818-824. |
[1] | SUN Qiyue, ZHAO Ronghua, BAO Lei, GUO Shanshan, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Safe doses of Lingyang Ganmao oral liquid for children based on the multi-animal model [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 121-126. |
[2] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
[3] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
[4] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
[5] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
[6] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[7] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
[8] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
[9] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
[10] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
[11] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
[12] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
[13] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
[14] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
[15] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||